Top 15 Biotechnology Angel Investors in China in May 2026

Portfolio highlights

• Sofía — Improving the way millions of people take care of their health
• Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
• Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Portfolio highlights

• Shanmu SHANMU — Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles.
• LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.
• Qingxian Intelligence — Qingxian Intelligence is a smart office and home office technology company. The company focuses on smart, comfortable, and healthy office scenarios.

Portfolio highlights

• PAM2L Biotechnologies — Boyin Bio is an innovative biomaterial research and development and application enterprise.

Portfolio highlights

• Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.

Portfolio highlights

• Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.

Portfolio highlights

• KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
• CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.
• Jiansheng Medicine — Jianersheng Pharmaceutical is a manufacturer of heavy metal detoxification drugs. It company is primarily involved in the research, development, and sale of special heavy metal detoxification drugs, such as special heavy metal detoxifiers and heavy metal diagnostic rapid detection kits.

Portfolio highlights

• Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

Portfolio highlights

• St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
• Hengyu Biotechnology — Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.

Portfolio highlights

• Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.

Portfolio highlights

• NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.

Portfolio highlights

• Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.

Portfolio highlights

• FangDD — FangDD is the an O2O real estate platform in China. It facilitates transactions between property sellers and home buyers through real estate brokers. FangDD works on a "pay-for-performance" business model instead of charging fees for every listings different from other domestic online estate services that charge customers for listingproperty information on the platforms, like SouFun and Anjuke.Currently, FangDD is in cooperation with over 100,000+ brokers, has offices in more than 30 cities and employs around 2500 people."In the first six months of this year(2014), Fangdd’s platform has seen more than 50 billion yuan ($8 billion) worth of real-estate transactions, and is aiming for 150 billion yuan worth of transactions for all of 2014" - Mr. Cao (Lightspeed China Partner).
• Hommily — Hommily is a new peer to peer social travel network helping connect travelers to locals from around the globe. Hommily makes it easy to connect with locals for tours, events, drivers, and activities during your trip.
• Locale — The Bay Area's best bakeries, restaurants and produce all in one delivery

Portfolio highlights

• Yiweisen — Yiweisen is a research and development firm that manufactures functional natural compound raw materials.

Portfolio highlights

• Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).

Portfolio highlights

• Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.